e-learning
resources
ERJ
2014
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
MicroRNA clusters: dysregulation in lung adenocarcinoma and COPD
Molina-Pinelo Sonia, Pastor M. Dolores, Suarez Rocío, Romero-Romero Beatriz, González De la Peña Miriam, Salinas Ana, García-Carbonero Rocío, De Miguel María José, Rodríguez-Panadero Francisco, Carnero Amancio, Paz-Ares Luis
Source:
Eur Respir J 2014; 43: 1740-1749
Journal Issue:
June
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Molina-Pinelo Sonia, Pastor M. Dolores, Suarez Rocío, Romero-Romero Beatriz, González De la Peña Miriam, Salinas Ana, García-Carbonero Rocío, De Miguel María José, Rodríguez-Panadero Francisco, Carnero Amancio, Paz-Ares Luis. MicroRNA clusters: dysregulation in lung adenocarcinoma and COPD. Eur Respir J 2014; 43: 1740-1749
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Increased sirtuin expression in patient with lung squamous cell carcinoma co-morbid with COPD
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015
Expression analysis of miR-223 in plasma of patients with non-small cell lung cancer and other obstructive lung diseases
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018
Multi-omic molecular profiling of lung cancer in COPD
Source: Eur Respir J, 52 (1) 1702665; 10.1183/13993003.02665-2017
Year: 2018
Evolution of microRNA expression during human bronchial squamous carcinogenesis
Source: Eur Respir J 2009; 33: 352-359
Year: 2009
Molecular signatures of non-small cell lung cancer (NSCLC) obtained from gene expression profiling of the benign bronchial mucosa of smokers with and without NSCLC
Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer
Year: 2013
Non-small cell lung cancer resected molecular expression in COPD and low function pulmonary patients
Source: Annual Congress 2007 - Biology, diagnosis and rare tumours in thoracic malignancies
Year: 2007
DNA methylation profiling of non-small cell lung cancer reveals an immune signature in COPD patients
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013
Airway gene expression as a link between COPD and lung cancer
Source: Annual Congress 2009 - The lung cancer-COPD nexus
Year: 2009
Subtypes of lung adenocarcinomas associated with IPF
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019
Causal RNA signatures in lung adenocarcinoma
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020
Gene expression profiles in non-small cell lung cancer (NSCLC) and lung tissue in smokers and non-smokers
Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer
Year: 2009
Expression of PD1, COPD and lung cancer.
Source: International Congress 2018 – Lung cancer: modern therapies and beyond
Year: 2018
Coexistence of COPD in lung cancer patients
Source: Eur Respir J 2001; 18: Suppl. 33, 66s
Year: 2001
Epigenetics in IPF and lung cancer
Source: Research Seminar 2015
Year: 2015
Gene expression profile in lung adenocarcinoma and non-cancerous lung tissue
Source: Eur Respir J 2005; 26: Suppl. 49, 456s
Year: 2005
Analysis and comparison of the transcriptome of COPD patients with and without lung cancer
Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond
Year: 2018
Increased expression of a proliferation-inducing ligand (APRIL) in lung leukocytes and alveolar epithelial cells in COPD patients with non small cell lung cancer: A possible link between COPD and lung cancer?
Source: International Congress 2016 – Mechanisms of disease
Year: 2016
Profiling of COPD and IPF cytokine responses in human lung
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021
Gene regulation of apoptosis and telomere length in COPD and lung cancer
Source: Annual Congress 2011 - New mechanisms in airway disease
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept